Covestor’s Karuna Therapeutics, Inc. Common Stock KRTX Stock Holding History

Covestor’s Portfolio KRTX Stock Details KRTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-41	Closed	-$13K	–	2892
2023 Q4	$13K	Hold	41	–	–	0.01%	1407
2023 Q3	$7K	Hold	41	–	–	0.01%	1653
2023 Q2	$9K	Hold	41	–	–	0.01%	1551
2023 Q1	$8K	Sell	41 -1	-2%	-$191	0.01%	1452
2022 Q4	$8K	Buy	42 +40	+2,000%	+$8.58K	0.01%	1450
2022 Q3	$1K	Sell	2 -1	-33%	-$202	﹤0.01%	1891
2022 Q2	$0	Sell	3 -1	-25%	-$115	﹤0.01%	2479
2022 Q1	$1K	Sell	4 -1	-20%	-$113	﹤0.01%	2017
2021 Q4	$1K	Buy	+5	New	+$646	﹤0.01%	2031

Other funds holding KRTX

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Sachetta Lynnfield, Massachusetts $206M AUM 26.19% 1-Year Est. Return

Covestor's KRTX Position: Q1 2024 in Review

Covestor sold out of Karuna Therapeutics, Inc. Common Stock (KRTX) in Q1 2024, closing a stake of 41 shares — an estimated $13K sold.

Covestor first reported a position in KRTX in Q4 2021 and held it in 9 quarters. The position peaked at $13K in Q4 2023. 2 funds tracked by Wall St. Rank hold KRTX as of Q1 2024.

Covestor reported no remaining Karuna Therapeutics, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
Covestor sold 41 Karuna Therapeutics, Inc. Common Stock shares in Q1 2024, an estimated $13K.
Covestor first reported a position in Karuna Therapeutics, Inc. Common Stock in Q4 2021 and held it in 9 quarters.
Covestor's Karuna Therapeutics, Inc. Common Stock position peaked at $13K in Q4 2023.
2 funds tracked by Wall St. Rank held Karuna Therapeutics, Inc. Common Stock as of Q1 2024.

Based on Covestor's 13F filing for Q1 2024, filed 10 May 2024.